Sublingual/Buccal buprenorphine and dental problems: a pharmacovigilance study
Author:
Affiliation:
1. Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, Toulouse University Hospital, Faculty of Medicine, Toulouse, France
Publisher
Informa UK Limited
Subject
Pharmacology (medical),General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/14740338.2023.2247962
Reference23 articles.
1. A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain
2. Buprenorphine and Naloxone Sublingual Tablets (2 mg/0.5 mg and 8 mg/2 mg) (buprenorphine/naloxone) dose indications adverse effects interactions… from PDR.net. https://www.pdr.net/drug-summary/Buprenorphine-and-Naloxone-Sublingual-Tablets–2-mg-0-5-mg-and-8-mg-2-mg–buprenorphine-naloxone-3772 (consulté le 26 jui 2023).
3. Methadone Hydrochloride Oral Concentrate USP 10 mg per mL(Dye-Free Sugar-Free Unflavored) andMethadone Hydrochloride Oral Concentrate USP 10 mg per mL(Cherry).
4. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
5. Management of Opioid Addiction With Opioid Substitution Treatments: Beyond Methadone and Buprenorphine
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3